These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Insulin antibodies in diabetics receiving a single type of insulin. Mincu I; Cheţa D Med Interne; 1982; 20(1):9-13. PubMed ID: 6765628 [TBL] [Abstract][Full Text] [Related]
7. [The antigenicity of various new chromatographically purified depot insulin preparations]. Graber D; Fankhauser S Schweiz Med Wochenschr; 1978 Nov; 108(46):1807-9. PubMed ID: 715418 [TBL] [Abstract][Full Text] [Related]
8. [Experiences in the treatment of diabetes with insulins of monocomponent (MC) and monospecies (MS) type]. Andreani D; Iavicoli M; Colletti A; Menzinger G Folia Endocrinol; 1972 Dec; 25(6):516-39. PubMed ID: 4581824 [No Abstract] [Full Text] [Related]
9. Behaviour of insulin antibodies in diabetics treated with different insulins. Mincu I; Cheţa D; Ionescu-Tîrgovişte C; Mirodon Z; Sîntu E Med Interne; 1980; 18(4):347-52. PubMed ID: 7006044 [TBL] [Abstract][Full Text] [Related]
10. Effect of lente insulin for treatment of diabetes mellitus in 12 cats. Bertoy EH; Nelson RW; Feldman EC J Am Vet Med Assoc; 1995 Jun; 206(11):1729-31. PubMed ID: 7782245 [TBL] [Abstract][Full Text] [Related]
11. [Advances in insulin treatment. Evaluation of isophane or lente insulin, mixed with rapid insulin and injected twice-a-day]. Cucinotta D; Lunetta M Minerva Endocrinol; 1990; 15(2):111-6. PubMed ID: 2098651 [TBL] [Abstract][Full Text] [Related]
12. [Changes in daily insulin requirement in diabetics switched to monocomponent insulin treatment]. Bruni B; Turco GL Minerva Med; 1973 Nov; 64(80):4224-31. PubMed ID: 4765430 [No Abstract] [Full Text] [Related]
13. [The place of "monocomponent" insulins in diabetes mellitus therapy]. Teuscher A Schweiz Med Wochenschr; 1975 Apr; 105(16):485-94. PubMed ID: 1215860 [TBL] [Abstract][Full Text] [Related]
14. [Evaluation of the antibody anti-insulin titer using Christiansen's radioimmunoelectrophoresis in clinical diabetology]. Bruni Bocher K; Castellazzi R; D'Adda A; Gamba S; Giolitti A; Rittatore R; Turco GL; Bruni B Ann Osp Maria Vittoria Torino; 1975; 18(1-6):26-52. PubMed ID: 1242089 [TBL] [Abstract][Full Text] [Related]
15. Comparison of insulin antibody levels during the first 3 years of treatment of adult diabetics with monocomponent porcine lente-insulin and single peak beef NPH insulin. Wajchenberg BL; Thomsen YG; Toledo e Souza IT; Germek OA Horm Metab Res; 1986 Aug; 18(8):535-9. PubMed ID: 3758926 [TBL] [Abstract][Full Text] [Related]
16. [Clinical use of NPH insulin (author's transl)]. Roesner M; Sauer H Dtsch Med Wochenschr; 1976 Jun; 101(23):886-9. PubMed ID: 1269430 [TBL] [Abstract][Full Text] [Related]
17. Injection of acidic or neutral insulin and pain: a single-center, prospective, controlled, noninterventional study in pediatric patients with type 1 diabetes mellitus. Karges B; Muche R; Riegger I; Moritz M; Heinze E; Debatin KM; Wabitsch M; Karges W Clin Ther; 2006 Dec; 28(12):2094-101. PubMed ID: 17296465 [TBL] [Abstract][Full Text] [Related]
18. [Therapeutic qualities of a lente preparation of swine insulins manufactured by Pharmachem]. Andreev D; Bozadzhieva E; Pampulov L; Penchev I; Uzunova B Vutr Boles; 1977; 16(6):59-66. PubMed ID: 341532 [TBL] [Abstract][Full Text] [Related]
19. Mixtard 30 HM Penfill insulin treatment in selected young insulin-dependent diabetes mellitus patients. Romanian Young Diabetics Study Team (RYDST). Rom J Intern Med; 1997; 35(1-4):99-113. PubMed ID: 9562659 [TBL] [Abstract][Full Text] [Related]
20. Immunogenicity of human insulin (Novo) or pork monocomponent insulin in HLA-DR-typed insulin-dependent diabetic individuals. Schernthaner G; Borkenstein M; Fink M; Mayr WR; Menzel J; Schober E Diabetes Care; 1983; 6 Suppl 1():43-8. PubMed ID: 6343038 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]